← Browse by Condition
Medical Condition

egfr amplification

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04429542 Phase 1
Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics
View Trial →